• Medical Oncology
• Weill Medical College, Cornell University - Medicine
• Memorial Sloan-Kettering Cancer Center - Medical Oncology
• University of Maryland Medical System - Internal Medicine
• Harvard Medical School - MD
Dr. Gregory Springett is a medical oncologist in the department of Gastrointestinal Oncology at Moffitt Cancer Center. He is an assistant professor of oncology at the University of South Florida College of Medicine.
Dr. Springett’s clinical interests include pancreatic cancer, and his research focuses on biomarker-driven therapeutic trials, including study of LPAAT-beta as a prognostic marker for ovarian and pancreatic cancer and study of MK-2461 (a selective inhibitor of c-Met, an oncogene that contributes to malignant transformation and tumor cell metastasis in patients with advanced cancer).
Dr. Springett received his medical degree from Harvard Medical School in Boston and a Ph.D. in cell biology from Massachusetts Institute of Technology. He completed a residency in internal medical at the University of Maryland and a fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center concurrent with a fellowship in medicine at Weil Cornell Medical College, Cornell University in New York.
Dr. Springett has been widely published in more than 48 peer-reviewed publications. He is a member of the American Cancer Society Grant Review Committee and Moffitt’s Clinical Pathways Development Committee.